secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001193125-24-008562
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DH CEO Musslewhite steps down; Founder Krantz interim CEO; reaffirms Q4 guidance, issues 2024 preview
--------------------------------------------------------------------------------

- CEO Robert Musslewhite resigned effective Jan 16, 2024; departure is without cause; receives 15 months accelerated vesting and up to $15K in legal fees.
- Founder and Executive Chairman Jason Krantz appointed interim CEO, effective Jan 16, 2024; Board engaged search firm for permanent CEO.
- Company reaffirms Q4 2023 guidance provided on Nov 3, 2023; preliminary 2024 guidance: revenue growth 5-7% YoY, Adj. EBITDA margin +~200 bps.
- Krantz previously served as CEO from 2011 to Aug 2022, scaling the company to >$200M revenue and IPO in Sept 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/d683059d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-008562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer